Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 24
» View wsbtradio.com items only
    Apr 16, 2013 |Story| Hartford Courant
  1. Thermo Fisher To Buy Life Tech For $13.6 Billion

    Thermo Fisher Scientific Inc. on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would make it one of the top two companies in the hot field of genetic testing. The pact values Life Tech at $76 per share, a 12 percent...

    Tags: Blackstone Group, L.P., Mergers, Acquisitions and Takeovers, Economy, Business and Finance, Corporate Officers, Illumina, Inc.

  2. Dec 13, 2012 |Story| Reuters
  3. More pressure to justify cost of cancer drugs versus benefits

    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments.
    Reuters
    (Reuters) - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could launch a high-priced drug with little push back. But now, there...

    Tags: Bevacizumab (drug), Corporate Officers, Healthcare Provider, Insurance, Chemical Industry

  4. Feb 1, 2012 | Allentown Morning Call
  5. New help for basal cell skin cancer patients

    Health
    On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell...
  6. May 23, 2011 |Story| Reuters
  7. Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
    Reuters
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...

    Tags: Health, Human Body, Corporate Officers, Liver Disease, Hepatitis

  8. May 26, 2011 |Story| Reuters
  9. |Story
  10. Jul 23, 2006 |Story| Tribune Media Services
  11. Sep 17, 2006 |Story| Tribune Media Services
  12. Jun 19, 2007 |Story| Chicago Tribune
  13. Manager seeks growth, income for Janus fund

    Tribune Media Services columnist
    Q. I'd like to know more about Janus Growth & Income Fund, which was recommended to me. A. Minyoung Sohn, the fund's portfolio manager since early 2004, seeks both capital appreciation and income. The $6.8 billion Janus Growth & Income Fund (JAGIX),...

    Tags: EnCanaCorporation, Health, EMC Corporation, Citigroup Incorporated, Periodicals

  14. Aug 26, 2007 |Story| Tribune Media Services
  15. Oct 7, 2007 |Story| Tribune Media Services
  16. Aug 12, 2007 |Story| Tribune Media Services
  17. Oct 19, 2005 |Story| Chicago Tribune
  18. U.S. lags on bird flu vaccine

    Tribune staff reporter
    Should a deadly bird flu spread quickly around the world, Americans could find themselves at the back of the line for any new vaccine developed to combat it. There are few U.S. vaccine makers. And even those, such as Deerfield-based Baxter...

    Tags: Plant Openings, Death, Companies and Corporations, University of Chicago, Health and Safety at School

< Previous1  2 
Original site for Roche Holding AG topic gallery.